{
    "pmcid": "7556756",
    "qa_pairs": {
        "How did the dimerization of monobodies affect their binding affinity?": [
            "It enhanced their binding affinity due to an avidity effect",
            "It decreased their binding affinity due to steric hindrance",
            "It had no effect on their binding affinity",
            "It caused a loss of binding affinity due to structural instability"
        ],
        "What advantage do nanobodies have that makes them suitable for therapeutic applications?": [
            "Small size, stability, and ease of production",
            "High immunogenicity and complex structure",
            "Long half-life and high molecular weight",
            "Ability to undergo glycosylation and complex folding"
        ],
        "What method was used to expedite the selection process of antibody-like proteins against the SARS-CoV-2 spike protein?": [
            "TRAP display",
            "Phage display",
            "Yeast surface display",
            "Ribosome display"
        ],
        "What was the purpose of using biotinylated SARS-CoV-2 spike protein targets in the study?": [
            "To enrich high-affinity binders through multiple rounds of selection",
            "To increase the immunogenicity of the spike protein",
            "To facilitate the glycosylation of the spike protein",
            "To enhance the stability of the spike protein"
        ],
        "Which monobody clone demonstrated a low half-maximal inhibitory concentration (IC50) against SARS-CoV-2 infection in vitro?": [
            "Monobody clone 6b",
            "Monobody clone 3a",
            "Monobody clone 5c",
            "Monobody clone 2d"
        ]
    }
}